NMRA logo

NMRANeumora Therapeutics Inc.

$1.78
$0.18
(11.25%)
Today
Closed $1.78
$0.03
(1.69%)
After Hours
Updated: 07:59 PM EDT
EarningsAug 6
Mkt Cap$296.45M
Vol1.15M

About

Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. The firm offers a precision medicine approach for brain diseases through the integration of data science and neuroscience. It focuses on advancing medicines for therapeutically relevant targets implicated in CNS diseases, targeting novel mechanisms of action with best-in-class pharmacology. The company was founded by Paul L. Berns, Carol Suh and Mike Poole in November 2019 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
96

Frequently Asked Questions

What is Market Cap of Neumora Therapeutics Inc.?
What is the 52-week high for Neumora Therapeutics Inc.?
What is the 52-week low for Neumora Therapeutics Inc.?
What is Neumora Therapeutics Inc. stock price today?
What was Neumora Therapeutics Inc. stock price yesterday?
What is the PE ratio of Neumora Therapeutics Inc.?
What is the Price-to-Book ratio of Neumora Therapeutics Inc.?
What is the 50-day moving average of Neumora Therapeutics Inc.?
How many employees does Neumora Therapeutics Inc. have?

Advertisement|Remove ads.